Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

Use the search and filter options below to find the resources you're looking for.

2178 Resources
2178 Resources
2178 Resources
    Date
    From
    To
  1. In Myanmar, non-communicable diseases (NCDs) have been recognized as a public health priority in the National Health Plan (NHP) (2011–2016). The NCD screening Response led by Community (NCR) project in Myanmar is dedicated to tackling the high prevalence of NCDs in the country. The project aims to enhance access to prevention, treatment, and care for NCDs through local engagement and the utilization of digital health solutions.PATH is providing valuable technical support and capacity-building to health care providers and community volunteers, focusing on NCDs and mental health. PATH is also providing comprehensive training programs for community volunteers, empowering them to conduct screenings and make referrals for NCD patients at the community level.In this brief, we talk about how improved access to prevention, treatment, and care for NCDs as part of PHC through local ownership and engagement guided by digital health and technical support has reduced premature morbidity and mortality due to NCDs.
    Published: May 2023
    Resource Page
    Brief
  2. In early 2023, the World Health Organization (WHO) Executive Board recommended to the seventy-sixth World Health Assembly the adoption of the resolution on increasing access to medical oxygen. The draft decision was submitted by Uganda and co-sponsored by Australia, Bangladesh, the Central African Republic, the European Union and its 27 member states, Kenya, and Turkey.This resolution recognizes and reaffirms the critical role of medical oxygen in resilient health systems planning and in achieving the Sustainable Development Goals for health. It upholds the urgency of sustaining investment in oxygen production and supply and calls on global stakeholders and national governments to continue alignment and coordination, including on policies and guidelines, technical documents, and training.
    Published: May 2023
    Resource Page
    Brief
  3. This slide provides a snapshot of the respiratory syncytial virus (RSV) vaccine and monoclonal antibody (mAb) technology landscape, in the effort to track the development of RSV vaccine and mAb candidates and provide a summary of the various vaccine approaches being worked on worldwide. (This snapshot pairs with the RSV and mAb Trial Tracker, which provides publicly available information on clinical trials of RSV candidate vaccines and mAbs intended for prevention.)
    Published: May 2023
    Resource Page
    Part of a Series, Infographic, Training Material, Brief
  4. In Kenya’s Kakamega County, citizen-led social accountability projects and data-driven advocacy led by the Kakamega County Maternal, Newborn, and Child Health Civil Society Organizations Alliance (MNCH Alliance), with support from PATH, have created a sustainable model for holding local decision-makers accountable and significantly improved health outcomes and quality of care for women and children in the county.
    Published: May 2023
    Resource Page
    Brief
  5. PATH conducted a series of studies to better understand the public health value of potential Shigella vaccines and help inform decisions by international agencies, funders, vaccine developers, and national policymakers. This report focuses on the results from a market assessment on Shigella vaccines for use in traveler and military populations. It aims to provide a better understanding of the size and specific segments of these markets, as well as an evaluation of the factors that may impact demand and utilization of these vaccines. The traveler and military markets are but one segment of a larger global Shigella vaccine market which has enormous potential to impact global health among children and adults in low- and middle-income countries.
    Published: April 2023
    Resource Page
    Report